Outcomes of patients with PSA above 20 ng/ml and benign prostatic biopsy: indications for rebiopsy

被引：0
|
作者：
Jones, CM [1 ]
Shaida, N [1 ]
Malone, PR [1 ]
机构：
[1] Royal Berkshire & Battle NHS Trust, Reading, Berks, England
来源：
BJU INTERNATIONAL | 2005年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
P69
引用
收藏
页码：62 / 62
页数：1
相关论文
共 50 条
  • [21] Serum and tissue monocyte differentiation in PSA value 4-10 ng/mL prostate cancer and benign prostatic hyperplasia
    Guo, Yuanyuan
    Liu, Beibei
    Liu, Jianmin
    Wang, Sheng
    Wang, Rui
    Chang, Rui
    Sun, Wenyan
    Ma, Tantu
    Li, Qingwen
    EUROPEAN JOURNAL OF INFLAMMATION, 2018, 16
  • [22] Surgical and Oncological Outcomes in Patients with Preoperative PSA >20 ng/ml Undergoing Robot-assisted Radical Prostatectomy
    Zugor, Vahudin
    Witt, Jorn H.
    Heidenreich, Axel
    Porres, Daniel
    Labanaris, Apostolos P.
    ANTICANCER RESEARCH, 2012, 32 (05) : 2091 - 2095
  • [23] Outcome of prostate cancer patients with initial PSA≥ 20 ng/ml undergoing radical prostatectomy
    Zweryel, Ulrike
    Suttmann, Henrik
    Schroeder, Thomas
    Siemer, Stefan
    Wullich, Bernd
    Kamradt, Joern
    Lehmann, Jan
    Stoeckle, Michael
    EUROPEAN UROLOGY, 2007, 52 (04) : 1058 - 1066
  • [24] Radical Prostatectomy as a First-Line Treatment in Patients with Initial PSA >20 ng/mL
    Hinev, Alexander I.
    Anakievski, Deyan
    Hadjiev, Vesselin I.
    INTERNATIONAL JOURNAL OF SURGICAL ONCOLOGY, 2012, 2012
  • [25] Should we biopsy men with PSA of 2.6-4.0 ng/mL?
    Zhu, H
    Roehl, KA
    Antenor, JAV
    Catalona, WJ
    JOURNAL OF UROLOGY, 2003, 169 (04): : 276 - 276
  • [26] Prognostic stratification of patients with PSA greater than 20 ng/ml undergoing radical prostatectomy
    Kawakami, S.
    Yano, M.
    Yamada, T.
    Yamamoto, S.
    Urakami, S.
    Fujii, Y.
    Yonese, J.
    Fukui, I
    Numao, N.
    Saito, K.
    Koga, F.
    Kihara, K.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E353 - U808
  • [27] How Much Digital Rectal Examination is Valuable for the Decision of Biopsy in Patients with PSA <= 4 ng/ml?
    Aydogdu, Ozgu
    Bozkurt, Ibrahim Halil
    Yonguc, Tarik
    Degirmenci, Tansu
    Polat, Salih
    Gunlusoy, Bulent
    Kucukturkmen, Ibrahim
    Ceylan, Yasin
    Minareci, Suleyman
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2015, 14 (01): : 1 - 4
  • [28] Epidemiological evidence suggesting a PSA cutpoint of 2.5 ng/ml for initiating a prostate biopsy: A review of 36,316 patients with biopsy and PSA data
    Lowe, FC
    Cavallo, CB
    Kahane, H
    JOURNAL OF UROLOGY, 2003, 169 (04): : 341 - 341
  • [29] Effects of antibacterial therapy on PSA change in the presence and absence of prostatic inflammation in patients with PSA levels between 4 and 10 ng/ml
    Kaygisiz, O.
    Ugurlu, Oe
    Kosan, M.
    Inal, G.
    Oeztuerk, B.
    Cetinkaya, M.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2006, 9 (03) : 235 - 238
  • [30] Effects of antibacterial therapy on PSA change in the presence and absence of prostatic inflammation in patients with PSA levels between 4 and 10 ng/ml
    O Kaygısız
    Ö Uğurlu
    M Koşan
    G İnal
    B Öztürk
    M Çetinkaya
    Prostate Cancer and Prostatic Diseases, 2006, 9 : 235 - 238
12345